All
Global leader: Canadian derm to head World Medical Association
November 10th 2008Toronto - Canadian dermatologist Dana W. Hanson, M.D., has been elected the 2009-10 president of the World Medical Association (WMA), a France-based independent confederation of 94 national medical associations representing more than 8 million doctors worldwide.
Artes Medical announces enrollment reached for post-marketing study of ArteFill
November 4th 2008San Diego - Artes Medical has announced enrollment is completed in the 1,000-patient post-marketing study required by the Food and Drug Administration for ArteFill, the only FDA-approved non-resorbable dermal filler, according to Business Wire.
Getting sensitive: Repeated use of topical therapies for AD increases contact dermatitis risk
November 1st 2008Repeated use of topical therapies for atopic dermatitis may lead to sensitization that results in allergic contact dermatitis. In a recent study, investigators identified several risk factors that are significantly linked with sensitization to local atopic dermatitis therapies.
Skin Sense Award Gala: Foundation raises $900,000 at benefit event
November 1st 2008New York - The Skin Cancer Foundation raised almost $900,000 during its annual Skin Sense Award Gala, an event honoring those who have contributed to educating the public about the prevention, detection and treatment of skin cancer, according to a press release.
Growing threat: MRSA emergence poses infection problem for patients with AD
November 1st 2008Available data indicates that the number of MRSA infections is increasing in both AD patients and the general population, an expert says. Understanding innate immunity and antimicrobial peptide production may lead to new treatment modalities.
Looking at the links: SID initiative to probe connections between chronic disease, skin disorders
November 1st 2008Washington - The Society for Investigative Dermatology (SID) launched its multi-year initiative on the Burden of Skin Disease Co-Morbidities at an invitational scientific conference Oct. 15-16 in Bethesda, Md.
Direct talks: How do derms view DTC advertising?
November 1st 2008National report - According to a recently released study, the $5 billion a year that pharmaceutical companies spend on direct-to-consumer (DTC) advertising may not always be such a good investment. And to some dermatologists, DTC drug advertising may not always be such a good idea from a medical standpoint.
Bridging the gap: Connection, communication can ease clashes between generations of derms
November 1st 2008National report - With four generations of dermatologists rubbing elbows in medical schools and residency programs, and three generations working side by side in practice and other settings, it's no wonder that doctors of all ages are feeling frustrated.
Protecting your assets: All plans are not created equal
November 1st 2008Too many physicians over the last decade have sought cookie-cutter asset protection plans to give them some "peace of mind" that if they ever endure an outrageous malpractice case, they won't lose everything. While we admire these doctors' commitment to pro-actively managing their risk, we have to remind doctors that all "asset protection plans" are not created equal. In fact, many will not even "work" if they ever are relied on.
Finance: Trend setting: In a volatile economy, experts speculate what 2009 will bring
November 1st 2008As we near the end of 2008 - one of the most economically volatile years in my memory-it seems natural to wonder what the coming year will bring. Even in the most stable of economic times, predicting future developments is an unwise indulgence at best. In times like these, it's pure madness.
Physician's profile: Making connections: 'Happenstance' opens path for New Orleans dermatologist
November 1st 2008Erin Boh, M.D., Ph.D., professor and chairman of dermatology at Tulane University Health Sciences Center, New Orleans, says her life has been a series of seamless connections - or, as she puts it, happenstance.
Verrucous carcinoma: Case shows verrucous carcinoma, ILVEN have striking histologic similarities
November 1st 2008Because verrucous carcinoma and ILVEN can have striking histologic similarities, one expert recommends considering verrucous carcinoma in the differential diagnosis of ILVEN. Initial biopsies can be misleading, evidence from this case demonstrates.
Treating BCC: Imiquimod therapy sustains clearance for five years
November 1st 2008Several therapies are available for the treatment of superficial basal cell carcinoma (BCC), including excision, PDT, 5-fluorouracil and imiquimod; however, not all of them have the same safety and efficacy profile. A recent study proves that imiquimod is safe and effective for the treatment of superficial BCC and assures sustained clearance over at least five years.
Striking gold for AKs?: Trials show ingenol mebutate is a safe, effective, extremely rapid treatment
November 1st 2008Ingenol mebutate is taking the dermatology world by storm as it time and again proves its high efficacy and excellent safety profile in the treatment of AKs. Many dermatologists are eagerly awaiting FDA approval of this novel topical therapy in the United States.
Treating melasma: Copper bromide laser effectively targets vasculature
November 1st 2008Targeting the melanocytes in the hypermelanosis seen in melasma is a common and effective therapy. Many therapies exist, including topical approaches, lasers and light therapy. A new approach targeting the vasculature, not the melanocytes, using a copper bromide dual 578 nm yellow laser has proven very effective in the treatment of melasma, a recent study shows.
Postoperative complications: Academic audit identifies surgical standards, risk factors
November 1st 2008An audit conducted at a university dermatology department suggests that certain factors appear to increase patients' risk of postoperative complications, one of the audit's authors says. However, antibiotic use may reduce such complications, he adds.
Help for homebodies: New laser, light technologies allow patients to treat themselves
November 1st 2008As new laser technology continues to be introduced to the market, patients keep searching for the newest, latest and greatest device. The current trend seems to be centered on what patients can do themselves, minimizing the amount of time needed in the office.